🇺🇸 FDA
Patent

US 9145462

Glioblastoma multiforme-reactive antibodies and methods of use thereof

granted A61KA61K47/6843A61K51/1045

Quick answer

US patent 9145462 (Glioblastoma multiforme-reactive antibodies and methods of use thereof) held by The Regents of the University of California expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K47/6843, A61K51/1045, A61P, A61P35/00